0001728390-20-000018.txt : 20200206 0001728390-20-000018.hdr.sgml : 20200206 20200205190455 ACCESSION NUMBER: 0001728390-20-000018 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Section 3(c)(1) FILED AS OF DATE: 20200206 DATE AS OF CHANGE: 20200205 EFFECTIVENESS DATE: 20200206 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Bioverge Funds, EnClear Therapies II, a series of Bioverge Funds II, LLC CENTRAL INDEX KEY: 0001786499 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-353256 FILM NUMBER: 20580409 BUSINESS ADDRESS: STREET 1: PO BOX 171305 CITY: SALT LAKE CITY STATE: UT ZIP: 84117 BUSINESS PHONE: 8014190677 MAIL ADDRESS: STREET 1: PO BOX 171305 CITY: SALT LAKE CITY STATE: UT ZIP: 84117 FORMER COMPANY: FORMER CONFORMED NAME: Bioverge Funds, EnClear II, a Series of Bioverge Funds II, LLC DATE OF NAME CHANGE: 20190826 D/A 1 primary_doc.xml X0708 D/A LIVE 0001786499 Bioverge Funds, EnClear Therapies II, a series of Bioverge Funds II, LLC 6510 South Millrock Drive Suite 400 Salt Lake City UT UTAH 84121 (801) 419-0677 DELAWARE None Bioverge Funds, EnClear II, a Series of Bioverge Funds II, LLC Limited Liability Company true 2019 LLC LP Assure Fund Management II PO Box 171305 Salt Lake City UT UTAH 84117 Director Issuer's Manager Jeremy LLC Neilson PO Box 171305 Salt Lake City UT UTAH 84117 Executive Officer Managing Director of the Issuer's Manager Richard LLC Thoms PO Box 171305 Salt Lake City UT UTAH 84117 Executive Officer Officer of the Issuer's Manager Pooled Investment Fund Other Investment Fund false Decline to Disclose 06b 3C.1 true 0001786499-19-000002 2019-11-12 false true false 5000 166680 166680 0 false 26 0 0 8000 This amount represents a one time fixed cost to cover fund organizational and operating expenses. Bioverge Funds, EnClear Therapies II, a series of Bioverge Funds II, LLC Richard Thoms Richard Thoms Officer of the Issuer's Manager 2020-02-05